Johann Steiner1,2, Harald Prüss3, Stephan Köhler4, Thomas Frodl1,2, Alkomiet Hasan5, Peter Falkai5. 1. Department of Psychiatry and Psychotherapy, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany. 2. Center for Behavioral Brain Sciences, Magdeburg, Germany. 3. German Center for Neurodegenerative Diseases (DZNE) Berlin and Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany. 4. Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany. 5. Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
Abstract
Objectives: Despite intensive research, schizophrenia and schizoaffective disorders continue to be theoretical constructs that describe clinical syndromes and no pathophysiologically defined diseases. Moreover, there are no clear biomarkers at hand. Therefore, these diagnoses are still set up based on clinical ICD-10/DSM-5 criteria and the exclusion of alcohol-/drug-associated, systemic or other brain organic causes. Methods: Recently, autoimmune encephalitis with psychotic symptoms caused by specific antineuronal antibodies has been identified as a rare, but potentially treatable differential diagnosis. However, these inflammatory brain diseases are not reliably detected by our current routine diagnostic workup in psychiatry. This qualitative review provides structured diagnostic and therapeutic support for clinical practice. Results: Disturbances of consciousness and orientation, catatonia, speech dysfunction, focal neurological signs, epileptic seizures/EEG abnormalities or autonomic dysfunction are warning signs in psychiatric patients which should always induce cerebrospinal fluid analysis with determination of antineuronal autoantibodies. Currently established immunotherapy strategies are summarised, taking into account international expert advice.Conclusions: Guided by clinical warning signs, our qualitative review enables rapid and reliable diagnosis of definite autoimmune encephalitis. This is of high relevance for the affected individuals, since early and sufficiently intense immunotherapy often leads to a good prognosis despite severe illness.
Objectives: Despite intensive research, schizophrenia and schizoaffective disorders continue to be theoretical constructs that describe clinical syndromes and no pathophysiologically defined diseases. Moreover, there are no clear biomarkers at hand. Therefore, these diagnoses are still set up based on clinical ICD-10/DSM-5 criteria and the exclusion of alcohol-/drug-associated, systemic or other brain organic causes. Methods: Recently, autoimmune encephalitis with psychotic symptoms caused by specific antineuronal antibodies has been identified as a rare, but potentially treatable differential diagnosis. However, these inflammatory brain diseases are not reliably detected by our current routine diagnostic workup in psychiatry. This qualitative review provides structured diagnostic and therapeutic support for clinical practice. Results: Disturbances of consciousness and orientation, catatonia, speech dysfunction, focal neurological signs, epileptic seizures/EEG abnormalities or autonomic dysfunction are warning signs in psychiatricpatients which should always induce cerebrospinal fluid analysis with determination of antineuronal autoantibodies. Currently established immunotherapy strategies are summarised, taking into account international expert advice.Conclusions: Guided by clinical warning signs, our qualitative review enables rapid and reliable diagnosis of definite autoimmune encephalitis. This is of high relevance for the affected individuals, since early and sufficiently intense immunotherapy often leads to a good prognosis despite severe illness.
Authors: Dominique Endres; Frank Leypoldt; Karl Bechter; Alkomiet Hasan; Johann Steiner; Katharina Domschke; Klaus-Peter Wandinger; Peter Falkai; Volker Arolt; Oliver Stich; Sebastian Rauer; Harald Prüss; Ludger Tebartz van Elst Journal: Eur Arch Psychiatry Clin Neurosci Date: 2020-03-12 Impact factor: 5.270
Authors: Tim W Rattay; Pascal Martin; Debora Vittore; Holger Hengel; Idil Cebi; Johannes Tünnerhoff; Maria-Ioanna Stefanou; Jonatan F Hoffmann; Katrin von der Ehe; Johannes Klaus; Julia Vonderschmitt; Matthias L Herrmann; Paula Bombach; Hazar Al Barazi; Lena Zeltner; Janina Richter; Klaus Hesse; Kathrin N Eckstein; Stefan Klingberg; Dirk Wildgruber Journal: Sci Rep Date: 2021-03-30 Impact factor: 4.379
Authors: Christian G Bien; Cathrin Rohleder; Juliane K Mueller; Corinna I Bien; Dagmar Koethe; F Markus Leweke Journal: Front Psychiatry Date: 2021-03-26 Impact factor: 4.157
Authors: Johann Steiner; Thomas Frodl; Kolja Schiltz; Henrik Dobrowolny; Roland Jacobs; Brisa S Fernandes; Paul C Guest; Gabriela Meyer-Lotz; Katrin Borucki; Sabine Bahn; Bernhard Bogerts; Peter Falkai; Hans-Gert Bernstein Journal: Schizophr Bull Date: 2020-02-26 Impact factor: 9.306
Authors: Martin Lennart Schulze Westhoff; Johannes Ladwig; Johannes Heck; Rasmus Schülke; Adrian Groh; Maximilian Deest; Stefan Bleich; Helge Frieling; Kirsten Jahn Journal: Brain Sci Date: 2021-12-23